rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Roberto Cuca

COO and CFO

Company insider

Files Form 4 as: COO and CFO, TELA Bio; CFO, OraSure Technologies; Sr. VP and CFO, Trevena.

In numbers

Trades disclosed
52
Buys
9
Sells
0
Bought
$518K
Sold
$0
Companies
3
Companies where not an officer
0
First trade
20 Feb 2014
Last trade
23 Feb 2026
Last filed
24 Feb 2026

Companies traded

Where they are an officer
TELA TELA BioOfficer · Medical Devices · last 23 Feb 20267 buys · 0 sells
OSUR OraSure TechnologiesOfficer · Medical Devices · last 7 May 20211 buy · 0 sells
TrevenaOfficer · last 28 Feb 20181 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
23 Feb 2026filed 24 Feb 2026TELA TELA BioMedical DevicesSEC FORM 4 Code F$4,0095,234 at $0.766filing
23 Feb 2026filed 24 Feb 2026TELA TELA BioMedical DevicesSEC FORM 4 Code F$4,0305,234 at $0.77filing
21 Feb 2026filed 24 Feb 2026TELA TELA BioMedical DevicesSEC FORM 4 Code F$3,4294,780 at $0.7174filing
21 Feb 2026filed 24 Feb 2026TELA TELA BioMedical DevicesSEC FORM 4 Code F$3,4424,780 at $0.72filing
20 Feb 2026filed 24 Feb 2026TELA TELA BioMedical DevicesSEC FORM 4 Code A—57,000 at $0.00filing
20 Feb 2026filed 24 Feb 2026TELA TELA Biooption or derivative · Medical DevicesSEC FORM 4 Code A—85,000 at $0.00filing
20 Feb 2026filed 24 Feb 2026TELA TELA Biooption or derivative · Medical DevicesSEC FORM 4 Code A—85,000 at $0.00filing
20 Feb 2026filed 24 Feb 2026TELA TELA BioMedical DevicesSEC FORM 4 Code A—57,000 at $0.00filing
23 Feb 2025filed 25 Feb 2025TELA TELA BioMedical DevicesSEC FORM 4 Code F$14K5,234 at $2.72filing
21 Feb 2025filed 25 Feb 2025TELA TELA Biooption or derivative · Medical DevicesSEC FORM 4 Code A—83,800 at $0.00filing
21 Feb 2025filed 25 Feb 2025TELA TELA BioMedical DevicesSEC FORM 4 Code A—57,000 at $0.00filing
24 Oct 2024filed 24 Oct 2024TELA TELA BioMedical DevicesSEC FORM 4 Bought$145K64,444 at $2.25filing
23 Feb 2024filed 27 Feb 2024TELA TELA Biooption or derivative · Medical DevicesSEC FORM 4 Code A—42,700 at $0.00filing
23 Feb 2024filed 27 Feb 2024TELA TELA BioMedical DevicesSEC FORM 4 Code A—29,200 at $0.00filing
23 Feb 2024filed 27 Feb 2024TELA TELA BioMedical DevicesSEC FORM 4 Code F$20K2,785 at $7.07filing
14 Nov 2023filed 14 Nov 2023TELA TELA BioMedical DevicesSEC FORM 4 Bought$45K10,000 at $4.49filing
23 Feb 2023filed 27 Feb 2023TELA TELA Biooption or derivative · Medical DevicesSEC FORM 4 Code A—27,700 at $0.00filing
23 Feb 2023filed 27 Feb 2023TELA TELA BioMedical DevicesSEC FORM 4 Code A—17,700 at $0.00filing
23 Feb 2023filed 27 Feb 2023TELA TELA BioMedical DevicesSEC FORM 4 Code F$14K1,300 at $10.50filing
7 Jun 2022filed 7 Jun 2022TELA TELA BioMedical DevicesSEC FORM 4 Bought$83K15,000 at $5.50filing

News

TELA Bio (NASDAQ:TELA) versus Shoulder Innovations (NYSE:SI) Head to Head SurveyTELA · dailypolitical.com · 14 Oct 2026

0 headlines in the last 90 days name Roberto Cuca; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.

Sectors

Health Care8
Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Joseph H. CapperDirector · Director at TELA Bio, filing Form 4 there in the last year
William J. PlovanicDirector · Director at TELA Bio, filing Form 4 there in the last year
Steven Kyle BoydDirector · Director at Orasure Technologies, filing Form 4 there in the last year
John P. KennyDirector · Director at Orasure Technologies, filing Form 4 there in the last year
Heather C. GetzChief Executive Officer · Chief Executive Officer at TELA Bio, filing Form 4 there in the last year